P732: Identification of pathogenic expansions within FXN in individuals with suspected Friedreich ataxia diagnoses

P732: Identification of pathogenic expansions within FXN in individuals with suspected Friedreich ataxia diagnoses

Saved in:

Bibliographic Details
Main Authors:	Kaitlynne Bohm, Erin Sybouts, Carmen Noller, Ben Sullivan, Erik Strandberg, Luke Drury, Jim McKay, Rachel Clark
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774425011409
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome or the FXN locus in Friedreich’s ataxia
by: Jessalyn Grant-Bier, et al.
Published: (2025-04-01)

Genetics of Friedreich Ataxia
by: J Gordon Millichap
Published: (1997-06-01)

Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01)

Clinical and Genetic Diagnosis of Friedreich’s Ataxia
by: J Gordon Millichap
Published: (1998-05-01)

Content Validity of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia
by: Michele Potashman, et al.
Published: (2025-01-01)

The importance of central auditory evaluation in Friedreich's ataxia
by: Bianca Simone Zeigelboim, et al.

CARDIOMYOPATHY IN THE FRIEDREICH ATAXIA: CLINICAL PRESENTATION AND DIAGNOSTICS OF COMPLICATIONS
by: Е. I. Fomicheva, et al.
Published: (2017-11-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

Muscle Endurance Training in a Person with Friedreich’s Ataxia
by: Nicole T. McGarrell, et al.
Published: (2025-01-01)

A Case of Ataxia with Isolated Vitamin E Deficiency Initially Diagnosed as Friedreich’s Ataxia
by: Michael Bonello, et al.
Published: (2016-01-01)

R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome.
by: Matthias Groh, et al.
Published: (2014-05-01)

Clinical and molecular studies in five Brazilian cases of Friedreich ataxia Avaliação clínica e molecular de cinco pacientes brasileiros com ataxia de Friedreich
by: IDA V.D. SCHWARTZ, et al.
Published: (1999-03-01)

Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review
by: Álvaro Darriba, et al.
Published: (2025-05-01)

Case Report: Complex cardiac arrhythmia management in the ICU for an adolescent with Friedreich ataxia
by: Oluwatomini A. Fashina, et al.
Published: (2025-04-01)

Gait characteristics in people with Friedreich ataxia: daily life versus clinic measures
by: Hannah L. Casey, et al.
Published: (2025-03-01)

Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from One Year of Clinical Treatment
by: Katherine Gunther, et al.
Published: (2025-04-01)

Omaveloxolone, But Not Dimethyl Fumarate, Improves Cardiac Function in Friedreich's Ataxia Mice With Severe Cardiomyopathy
by: Lili Salinas, et al.
Published: (2025-06-01)

Alpha–lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia
by: Marta Talaverón-Rey, et al.
Published: (2025-08-01)

Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk
by: Andrea Quatrana, et al.
Published: (2025-04-01)

Anesthesia Management in Scoliosis Surgery of Patients with Friedreich’s Ataxia: A Report of Four Cases
by: Muhammed Köse, et al.
Published: (2022-12-01)

Precision medicine and Friedreich ataxia: promoting equity, beneficence, and informed consent for novel gene therapies
by: Faith A. A. Kwa, et al.
Published: (2024-11-01)

Harshly Oxidized Activated Charcoal Enhances Protein Persulfidation with Implications for Neurodegeneration as Exemplified by Friedreich’s Ataxia
by: Anh T. T. Vo, et al.
Published: (2024-12-01)

Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression
by: Jiaxing Guo, et al.
Published: (2025-05-01)

Anti-gene oligonucleotides targeting Friedreich’s ataxia expanded GAA⋅TTC repeats increase Frataxin expression
by: Negin Mozafari, et al.
Published: (2025-06-01)

Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.
by: Chiranjeevi Sandi, et al.
Published: (2014-01-01)

Robust behavioral assessment of the inducible Friedreich's ataxia mouse does not show improvement with NRF2 induction
by: Claire B. Montgomery, et al.
Published: (2025-03-01)

P289: Disease characteristics and tissue frataxin concentrations in adults with Friedreich’s ataxia participating in nomlabofusp interventional studies
by: Russell Clayton, et al.
Published: (2025-01-01)

Antisense oligonucleotide therapy for patients with Friedreich’s ataxia carrying the c.165+5G>C splicing mutation
by: Pouiré Yameogo, et al.
Published: (2025-09-01)

Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations
by: Susan Perlman, et al.
Published: (2025-06-01)

Abnormal visual cortex activity using functional magnetic resonance imaging in treatment resistant photophobia in Friedreich Ataxia
by: Araliya N. Gunawardene, et al.
Published: (2024-12-01)

Predictive machine learning and multimodal data to develop highly sensitive, composite biomarkers of disease progression in Friedreich ataxia
by: Susmita Saha, et al.
Published: (2025-05-01)

Electrical System Design of FXN5C AC Drive Freight Diesel Locomotive
by: Lanfeng MEI, et al.
Published: (2021-11-01)

Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich’s ataxia: insights from in vitro models
by: Fred Jonathan Edzeamey, et al.
Published: (2025-12-01)

Abordaje en la evaluación e intervención logopédica de pacientes con ataxia de Friedreich: revisión bibliográfica
by: Silvia Moreno Escobar, et al.
Published: (2025-07-01)

Efficiency of a 3-week multicomponent rehabilitation on improving the function in a patient with Friedreich’s ataxia: A case report
by: Samardžić Vesna
Published: (2023-01-01)

Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin.
by: Wolfgang Nachbauer, et al.
Published: (2013-01-01)

Friedreich’s Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases
by: Vamshi K. Rao, et al.
Published: (2018-01-01)

Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review
by: Ankita Umrao, et al.
Published: (2024-12-01)

Base excision repair of chemotherapeutically-induced alkylated DNA damage predominantly causes contractions of expanded GAA repeats associated with Friedreich's ataxia.
by: Yanhao Lai, et al.
Published: (2014-01-01)

Correction: A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.
by: Nellie Georgiou-Karistianis, et al.
Published: (2025-01-01)